Get the Stockscreener App
1.645
0.92%
0.015
Cerus Corp stock is traded at $1.645, with a volume of 508.24K.
It is up +0.92% in the last 24 hours and up +12.67% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
See More
Previous Close:
$1.63
Open:
$1.62
24h Volume:
508.24K
Relative Volume:
0.39
Market Cap:
$315.34M
Revenue:
$156.37M
Net Income/Loss:
$-37.49M
P/E Ratio:
-7.8333
EPS:
-0.21
Net Cash Flow:
$-47.77M
1W Performance:
+4.11%
1M Performance:
+12.67%
6M Performance:
+27.52%
1Y Performance:
-2.08%
1-Day Range:
$1.59
$1.66
1-Week Range:
$1.505
$1.68
52-Week Range:
$1.12
$2.235
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.645 | 312.47M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
128.27 | 225.41B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
99.86 | 148.96B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
378.90 | 145.74B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.98 | 123.04B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
76.01 | 44.20B | 5.69B | 1.41B | 577.90M | 6.9828 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
Cerus (NASDAQ: CERS) hosts IFC workshop, 18 abstracts slated for 2025 AABB Annual Meeting - Stock Titan
Relative strength of Cerus Corporation in sector analysisJuly 2025 Outlook & Growth Focused Entry Reports - newser.com
Real time pattern detection on Cerus Corporation stockOil Prices & Short-Term High Return Ideas - newser.com
Volatility clustering patterns for Cerus CorporationTrade Signal Summary & Real-Time Volume Triggers - newser.com
How Cerus Corporation (CU2) stock performs in volatility spikesInsider Selling & Smart Allocation Stock Tips - newser.com
Can a trend reversal in Cerus Corporation lead to recoveryJuly 2025 Summary & Free Daily Entry Point Trade Alerts - newser.com
Cerus Corporation stock trend forecastWeekly Trading Summary & Fast Gaining Stock Reports - newser.com
Will Cerus Corporation (CU2) stock outperform global peersForecast Cut & Consistent Profit Trading Strategies - newser.com
What momentum indicators show for Cerus Corporation stockFed Meeting & Target Return Focused Stock Picks - newser.com
Will Cerus Corporation (CU2) stock outperform small cap peersBull Run & Reliable Volume Spike Trade Alerts - newser.com
Why Cerus Corporation stock is popular among millennialsAnalyst Upgrade & Weekly Return Optimization Plans - newser.com
Can Cerus Corporation stock hit record highs againWeekly Gains Report & Accurate Intraday Trade Tips - newser.com
What does recent volatility data suggest for Cerus CorporationJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - newser.com
Signal strength of Cerus Corporation stock in tech scanners2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
Will a bounce in Cerus Corporation offer an exitBuy Signal & Verified Swing Trading Watchlists - newser.com
Backtesting results for Cerus Corporation trading strategiesJuly 2025 Closing Moves & Fast Exit/Entry Strategy Plans - newser.com
Can Cerus Corporation stock sustain market leadershipTrend Reversal & AI Based Buy/Sell Signal Reports - nchmf.gov.vn
Will Cerus Corporation (CU2) stock test record highs in 2025Weekly Trade Summary & High Win Rate Trade Tips - nchmf.gov.vn
Is Cerus Corporation stock recession proof2025 Year in Review & Long-Term Safe Return Strategies - nchmf.gov.vn
Why retail investors favor Cerus Corporation stockEarnings Beat & Pattern Based Trade Signal System - nchmf.gov.vn
Is Cerus Corporation stock a buy for dividend growthQuarterly Market Summary & Safe Capital Allocation Plans - newser.com
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025 - Business Wire
What’s the recovery path for long term holders of Cerus Corporation2025 Performance Recap & Risk Controlled Daily Plans - newser.com
Live market analysis of Cerus CorporationJuly 2025 Rallies & AI Driven Stock Reports - newser.com
Wealth Enhancement Advisory Services LLC Acquires 27,092 Shares of Cerus Corporation $CERS - Defense World
What is the fair value estimate for Cerus Corporation (CU2) stock in 20252025 Price Targets & Free Verified High Yield Trade Plans - newser.com
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cerus Corp Stock (CERS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
783,294 |
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):